A new analysis of prospective data from the Myelofibrosis and Essential Thrombocythemia Observational (MOST) study has identified a significant risk factor for myelofibrosis progression. Abdulraheem Yacoub, MD, of the University of Kansas Medical Center, and colleagues conducted the analysis and presented their findings during the 66th American Society of Hematology Annual Meeting and Exposition in San Diego, California. ...
Myelofibrosis
Learn more about the newest discoveries and latest clinical insights in myelofibrosis (MF). Cancer Nursing Today provides up-to-date perspectives and information on transplant trends in MF, novel therapeutic targets, and more. From promising new treatments to risk factors and prognostics, explore the latest developments in MF care.
Advertisement
Dr. Bose joined Cancer Nursing Today at ASH 2024 to share insights on using anemia-supporting medications with ruxolitinib.
Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO, discusses her experiences and shares resources.
An exploratory analysis of the MOMENTUM trial evaluated how the JAK inhibitor impacted OS and LFS in these patients.
Researchers developed and piloted a novel phone-delivered positive psychology intervention called PATH.
Interprofessional team-based care is the standard for patients undergoing HSCT. But who belongs on the team?
Higher baseline quality of life independently predicted longer overall survival in patients with myelofibrosis.
Pacritinib was found to be more effective than best available treatment at reducing spleen volume in myelofibrosis patients.
Adding navitoclax to ruxolitinib treatment in patients with persistent or progressive myelofibrosis led to durable splee
Myelofibrosis patients treated with fludarabine and busulfan along with TBI saw reduction in graft failure.
A trial examined weekly administration of LCL161 therapy in a large, high-risk, older study population with myelofibrosis ...
Advertisement
Trending
Studying for certification tests can be intimidating. Here are some essential tips to help you do your best.
These tips are important resources for oncology nurses who are recent graduates and experienced nurses new to this specialty.
With the shift in cancer care to the ambulatory care setting, a dedicated oncology nurse educator is a key asset to nurses.
Gastroparesis occurs in 60% of patients with advanced pancreatic cancer, and is frequently overlooked in upper GI tumors.
More unique, non-traditional jobs are emerging for oncology nurses to consider outside traditional positions.
Alkaline phosphatase may serve as a discriminating marker in detecting bone lesions in patients with multiple myeloma.
Advertisement
Advertisement
Latest News
Stephen R. Spellman shares highlights from the results of the ACCESS trial, which was presented at the 2025 Tandem Meetings.
Theresa Brown, RN, shares why it's key to educate patients on the complexity of medical decisions and risk-benefit analyses.
The study explored the characteristics of sick role adaptation in colorectal cancer and its differences across age groups.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.